SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SomaLogic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3448
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. SomaLogic’s SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions. It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. The company serves biological and medical science sectors. SomaLogic is headquartered in Boulder, Colorado, the US.

SomaLogic Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
Private Equity 15
SomaLogic Raises USD200 Million in Financing Round 15
Partnerships 16
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc – Key Competitors 17
SomaLogic Inc – Key Employees 18
SomaLogic Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Apr 02, 2018: Melody Harris, J.D., Appointed Chief Legal Officer of SomaLogic 20
Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 21
Government and Public Interest 22
Nov 16, 2017: An immune system timeline for tuberculosis progression 22
Oct 16, 2017: Modified DNA aptamer inhibits IL-1 alpha signaling 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
SomaLogic Inc, Pharmaceuticals & Healthcare, Key Facts 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
SomaLogic Raises USD200 Million in Financing Round 15
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc, Key Competitors 17
SomaLogic Inc, Key Employees 18

List of Figures
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Camlin Fine Sciences Ltd:企業の戦略・SWOT・財務情報
    Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • HUYA Bioscience International LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary HUYA Bioscience International LLC (HUYA) is a biopharmaceutical company that develops early and late-stage drug candidates. The company’s pipeline products include HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker …
  • Oilex Ltd (OEX):企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Silence Therapeutics Plc (SLN)-製薬・医療分野:企業M&A・提携分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Phoenix Brands LLC:企業の戦略・SWOT・財務情報
    Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report Summary Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Perceptron Inc (PRCP):企業の財務・戦略的SWOT分析
    Summary Perceptron Inc (Perceptron) is a technology company that produces, develops, and markets automated industrial metrology products and solutions. The company’s products include dimensional inspection, robot guidance, dimensional gauging, gap and flush solutions, 3D scanning, and metrology soft …
  • iXBlue SAS:企業の戦略的SWOT分析
    iXBlue SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Connect Catering Limited:企業の戦略・SWOT・財務情報
    Connect Catering Limited - Strategy, SWOT and Corporate Finance Report Summary Connect Catering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Leukocare AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • Aegis Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a drug-delivery and drug-formulation technologies company that commercializes drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. The company offers Intravail, …
  • San Miguel Power Association, Inc.:企業の戦略的SWOT分析
    San Miguel Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TUV Nord AG:企業の戦略的SWOT分析
    TUV Nord AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Nihon Unisys, Ltd.:企業の戦略・SWOT・財務情報
    Nihon Unisys, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nihon Unisys, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • First Solar Inc (FSLR)-エネルギー分野:企業M&A・提携分析
    Summary First Solar, Inc. (First Solar) is a provider of photovoltaic (PV) solar energy solutions. It designs, manufactures and sells PV solar modules with an advanced thin-film semiconductor technology; and also develops, designs, constructs and sells PV solar power systems. The company uses its Cd …
  • Syncardia Systems LLC:医療機器:M&Aディール及び事業提携情報
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆